Protagonist Therapeutics (PTGX)
NASDAQ:PTGX
Protagonist Therapeutics (PTGX) Ownership Overview
1.30% Insiders
20.73% Mutual Funds
40.84% Other Institutional Investors
23.68% ETFs
13.45% Public Companies and
Individual Investors
The ownership structure of Protagonist Therapeutics (PTGX) stock is a mix of institutional, retail, and individual investors. Approximately 85.25% of the company’s stock is owned by Institutional Investors, 1.30% is owned by Insiders, and 13.45% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 27, 2026 | xxxxxxxxxxxxx | $1571850 | |
Mar 27, 2026 | xxxxxxxxxxxxx | $2581504 | |
Mar 27, 2026 | xxxxxxxxxxxxx | $2520000 | |
Mar 25, 2026 | xxxxxxxxxxxxx | $5524700 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $1100484 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $5687056 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $8734000 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $96001507 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,843,723 | Institution | 10.73% | 665,415,187 | |
| 6,144,006 | Institution | 9.63% | 597,381,703 | |
| 4,478,252 | Institution | 7.02% | 435,420,442 | |
| 3,703,675 | Institution | 5.80% | 360,108,320 | |
| 2,002,578 | Institution | 3.14% | 194,710,659 | |
| 1,408,772 | Institution | 2.21% | 136,974,902 | |
| 1,350,425 | Institution | 2.12% | 131,301,823 | |
| 1,099,170 | Institution | 1.72% | 106,872,299 | |
| 1,062,977 | Institution | 1.67% | 103,353,254 | |
| 955,194 | Institution | 1.50% | 92,873,513 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,703,675 | Institution | 5.80% | 360,108,320 | |
| 1,062,977 | Institution | 1.67% | 103,353,254 | |
| 955,194 | Institution | 1.50% | 92,873,513 | |
| 907,796 | Institution | 1.42% | 88,265,005 | |
| 635,382 | Institution | 1.00% | 61,778,192 | |
| 581,027 | Institution | 0.91% | 56,493,255 | |
| 501,713 | Institution | 0.79% | 48,781,555 | |
| 455,214 | Institution | 0.71% | 44,260,457 | |
| 414,868 | Institution | 0.65% | 40,337,616 | |
| 400,021 | Institution | 0.63% | 38,894,042 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,566,132 | Institution | 5.59% | 346,735,014 | |
| 1,967,141 | Institution | 3.08% | 160,912,134 | |
| 1,438,052 | Institution | 2.25% | 139,821,796 | |
| 1,030,054 | Institution | 1.61% | 99,657,725 | |
| 708,030 | Institution | 1.11% | 57,916,854 | |
| 634,513 | Institution | 0.99% | 51,903,163 | |
| 545,261 | Institution | 0.85% | 52,754,002 | |
| 500,559 | Institution | 0.78% | 48,669,352 | |
| 489,905 | Institution | 0.77% | 47,633,463 | |
| 425,726 | Institution | 0.67% | 41,393,339 |
FAQ
Who Owns Protagonist Therapeutics (PTGX)?
According to the latest TipRanks data, approximately 40.84% of the company's stock is held by institutional investors, 1.30% is held by insiders, and 13.45% is held by retail investors.
What percentage of Protagonist Therapeutics (PTGX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 40.84% of Protagonist Therapeutics (PTGX) stock is held by institutional investors.
What percentage of Protagonist Therapeutics (PTGX) stock is held by retail investors?
According to the latest TipRanks data, approximately 13.45% of Protagonist Therapeutics (PTGX) stock is held by retail investors.
Who owns the most shares of Protagonist Therapeutics (PTGX)?
iShares owns the most shares of Protagonist Therapeutics (PTGX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.